Publications

5808 Results

Phase II study of Cediranib in patients with malignant pleural mesothelioma: SWOG S0509 [PMID21964533;PMC3477852]

Authors
L Garland;K Chansky;A Wozniak;A Tsao;S Gadgeel;C Verschraegen;M Da Silva;M Redman;M Gandara
Journal / Conference
Journal of Thoracic Oncology, Nov; 6(11):1938-1945;
Year
2011
Research Committee(s)
Lung
Study Number(s)
S0509

A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma (MPM) tumors by RECIST and modified RECIST criteria

Authors
A Tsao;L Garland;M Redman;K Kernstine;D Gandara;E Marom
Journal / Conference
Journal of Thoracic Oncology 6(3):598-601;
Year
2011
Research Committee(s)
Lung
PMID
PMID21270668
PMC
PMC3643692

Effect of physician recommendation on multivitamin and antioxidant supplement use during chemotherapy in an adjuvant trial for breast cancer (SWOG S0221)

Authors
G Zirpoli;PM Brennan;CC Hong;SC McCann;JM Unger;GT Budd;D Hershman;J Stewart;C Isaacs;T Hobday;M Salim;G Hortobagyi;J Gralow;K Albain;DF Hayes;C Ambrosone
Journal / Conference
American Association for Cancer Research 2011 Annual Meeting, accepted (poster);
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0221

Selenium supplementation and prostate cancer among men with high grade prostatic intraepithelial neoplasia: SWOG-directed intergroup trial S9917 [PMID21896650; PMC3208719]

Authors
JR Marshall;C Tangen;W Sakr;DP Wood;D Berry;E Klein;S Lippman;H Parnes;D Alberts;D Jarrard;WR Lee;JM Gaziano;ED Crawford;B Ely;M Ray;W Davis;L Minasian;IM Thompson
Journal / Conference
Cancer Prevention Research 4(11):1761-1769;
Year
2011
Research Committee(s)
Genitourinary
Study Number(s)
S9917

A randomized trial comparing 14-day triple, 10-day sequential, and 5-day concomitant therapy to eradicate Helicobacter pylori in seven Latin American populations

Authors
C Ferreccio;G Anderson;D Morgan;J Torres;LE Bravo;R Dominguez;R Herrero;M Meza-Montenegro;R Pena;E Salazar-Martinez;W Chey;M Valdivieso;J Crowley;G Goodman;ER Greenberg;LH Baker
Journal / Conference
Digestive Disease Week 2011 meeting, oral presentation
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0701

SWOG cooperative group biorepository resource: access for scientific research studies

Authors
C Hoban;W Franklin;K Kopecky;L Baker
Journal / Conference
Clinical Cancer Research 17(16):5239-5246;
Year
2011
Research Committee(s)
Molecular Epidemiology and Multiple sites
PMID
PMID21555374

A secure website for participant submission of follow-up data

Authors
J Hartline;A Smith;K Anderson
Journal / Conference
Society for Clinical Trials 2011 Annual Meeting, oral;
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) [PMID21766209; PMC33532924]

Authors
L Sucheston;H Zhao;S Yao;G Zirpoli;S Liu;W Barlow;HCF Moore;G Budd;D Hershman;W Davis;G Ciupak;J Stewart;C Isaacs;T Hobday;M Salim;G Hortobagyi;J Gralow;R Livingston;K Albain;D Hayes;C Ambrosone
Journal / Conference
Breast Cancer Research and Treatment, 130(3):993-1002;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0221

Study transition from local in-person follow-up to centralized follow-up by mail

Authors
K Anderson;J Hartline;J Harris-Talley
Journal / Conference
American Society of Preventive Oncology Annual Meeting 2011, poster presentation
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

The consent process for transitioning a large trial to centralized follow-up

Authors
M Yee;JA Hartline;K Anderson
Journal / Conference
American Society of Preventive Oncology Annual Meeting 2011, poster presentation
Year
2011
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000